Filing Details
- Accession Number:
- 0000950170-24-069680
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-06 08:26:55
- Reporting Period:
- 2024-06-05
- Accepted Time:
- 2024-06-06 08:26:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1339970 | Atyr Pharma Inc | ATYR | Biological Products, (No Disgnostic Substances) (2836) | 203435077 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1640869 | Nancy Denyes | 10240 Sorrento Valley Road Suite 300 San Diego CA 92121 | General Counsel | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-06-05 | 5,000 | $1.86 | 22,267 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.835 to $1.87 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
- Includes 2,500 shares acquired on May 15, 2024 under the Company's 2015 Employee Purchase Plan.
Billionaire Hedge Funds
